Cargando…
Pharmacometabolomics by NMR in Oncology: A Systematic Review
Pharmacometabolomics (PMx) studies aim to predict individual differences in treatment response and in the development of adverse effects associated with specific drug treatments. Overall, these studies inform us about how individuals will respond to a drug treatment based on their metabolic profiles...
Autores principales: | Gómez-Cebrián, Nuria, Vázquez Ferreiro, Pedro, Carrera Hueso, Francisco Javier, Poveda Andrés, José Luis, Puchades-Carrasco, Leonor, Pineda-Lucena, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539252/ https://www.ncbi.nlm.nih.gov/pubmed/34681239 http://dx.doi.org/10.3390/ph14101015 |
Ejemplares similares
-
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2022) -
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2023) -
Metabolomics Applications in Precision Medicine: An Oncological Perspective
por: Puchades-Carrasco, Leonor, et al.
Publicado: (2017) -
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2021) -
Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2019)